Inadequacy of thromboprophylaxis in hospitalized medical patients;Inadequação de tromboprofilaxia venosa em pacientes clínicos hospitalizados

Revista da Associacao Medica Brasileira

Volumn 52, Issue 6, 2006, Pages 441-446

  Rocha, Ana Thereza C ^a,b   Braga, Priscila ^a   Ritt, Guilherme ^a   Lopes, Antônio Alberto ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b Ed Mansão do Lena ^*  (Brazil)

Author keywords

Guidelines for medical practice; Heparin; Internal medicine; Prevention and control; Risk factors; Thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; ARTICLE; CROSS-SECTIONAL STUDY; FEMALE; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; PRACTICE GUIDELINE; REGRESSION ANALYSIS; RISK FACTOR; THROMBOEMBOLISM; VEIN THROMBOSIS;

ADULT; ANTICOAGULANTS; CROSS-SECTIONAL STUDIES; FEMALE; GUIDELINES; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RISK FACTORS; THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 33846810154     PISSN: 01044230     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0104-42302006000600026     Document Type: Article

References (19)

1. Kleber FX, Witt C, Vogel G, Koppenhagen K, Schomaker U, Flosbach CW. Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease. Am Heart J. 2003;145:614-21.
2. Kleber FX, Witt C, Flosbach CW. Study to compare the efficacy and safety of the LMWH enoxiparin and standard heparin in the prevention of thromboembolic events in medical patients with cardiopulmonary disease. Ann Hematol. 1998;76(Suppl):A93-5.
3. Samama MM, Cohen AT, Darmon JY, Desjardins L, Eldor A, Janbon C, et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med. 1999;341:793-800.
4. Geerts WH, Heit JA, Clagett GP, Pineo GF, Colwell CW, Anderson FA Jr, et al. Prevention of venous thromboembolism. Chest. 2001;119:132S-75S.
5. Alikhan R, Cohen AT, Combe S, Samama MM, Desjardins L, Eldor A, et al. Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study. Blood Coagul Fibrinolysis. 2003;14:341-6.
6. Alikhan R, Cohen AT, Combe S, Samama MM, Desjardins L, Eldor A, Janbon C, Leizorovicz A, Olsson CG, Turpie AG. Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study. Arch Intern Med. 2004;164:963-8.
7. Risk of and prophylaxis for venous thromboembolism in hospital patients. Thromboembolic Risk Factors (THRIFT) Consensus Group. BMJ. 1992;305:567-74.
8. Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, Ray JG. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126:338S-400S.
9. Keane MG, Ingenito EP, Goldhaber SZ. Utilization of venous thromboembolism prophylaxis in the medical intensive care unit. Chest. 1994;106:13-14
10. Goldhaber SZ, Dunn K, MacDougall RC. New onset of venous thromboembolism among hospitalized patients at Brigham and Women's Hospital is caused more often by prophylaxis failure than by withholding treatment. Chest. 2000;118:1680-4.
11. Ryskamp RP, Trottier SJ. Utilization of venous thromboembolism prophylaxis in a medical-surgical ICU. Chest. 1998;113:162-4.
12. Arnold DM, Kahn SR, Shrier I. Missed opportunities for prevention of venous thromboembolism: an evaluation of the use of thromboprophylaxis guidelines. Chest. 2001;120:1964-71.
13. Deheinzelin D, Braga AL, Martins LC, Martins MA, Hernandez A, Yoshida WB, et al. Incorrect use of thromboprophylaxis for venous thromboembolism in medical and surgical patients: results of a multicentric, observational and cross-sectional study in Brazil. J Thromb Haemost. 2006;4:1266-70.
14. Offord R, Lloyd AC, Anderson P, Bearne A. Economic evaluation of enoxaparin for the prevention of venous thromboembolism in acutely ill medical patients. Pharm World Sci. 2004;26:214-20.
15. Aujesky D, Guignard E, Pannatier A, Cornuz J. Pharmacological thromboembolic prophylaxis in a medical ward: room for improvement. J Gen Intern Med. 2002;17:788-91.
16. Rashid ST, Thursz MR, Razvi NA, Voller R, Orchard T, Rashid ST, Shlebak AA. Venous thromboprophylaxis in UK medical inpatients. J R Soc Med. 2005;98:507-12.
17. Goldhaber SZ, Tapson VF. A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis. Am J Cardiol. 2004;93:259-62.
18. Lacherade JC, Cook D, Heyland D, Chrusch C, Brochard L, Brun-Buisson C. Prevention of venous thromboembolism in critically ill medical patients: a Franco-Canadian cross-sectional study. J Crit Care. 2003;18:228-37.
19. Chopard P, Dorffler-Melly J, Hess U, Wuillemin WA, Hayoz D, Gallino A, et al. Venous thromboembolism prophylaxis in acutely ill medical patients: definite need for improvement. J Intern Med. 2005;257:352-7.